- Home
- AFG vs BMRN Comparison
AFG vs BMRN Comparison
Compare AFG & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFG
- BMRN
- Stock Information
- Founded
- AFG 1872
- BMRN 1996
- Country
- AFG United States
- BMRN United States
- Employees
- AFG N/A
- BMRN N/A
- Industry
- AFG Property-Casualty Insurers
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AFG Finance
- BMRN Health Care
- Exchange
- AFG Nasdaq
- BMRN Nasdaq
- Market Cap
- AFG 10.3B
- BMRN 12.1B
- IPO Year
- AFG N/A
- BMRN 1999
- Fundamental
- Price
- AFG $127.45
- BMRN $57.29
- Analyst Decision
- AFG Hold
- BMRN Buy
- Analyst Count
- AFG 3
- BMRN 22
- Target Price
- AFG $140.00
- BMRN $93.62
- AVG Volume (30 Days)
- AFG 542.2K
- BMRN 2.1M
- Earning Date
- AFG 08-05-2025
- BMRN 08-04-2025
- Dividend Yield
- AFG 2.51%
- BMRN N/A
- EPS Growth
- AFG N/A
- BMRN 152.82
- EPS
- AFG 9.52
- BMRN 2.71
- Revenue
- AFG $7,984,000,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- AFG N/A
- BMRN $12.27
- Revenue Next Year
- AFG $6.40
- BMRN $9.99
- P/E Ratio
- AFG $13.38
- BMRN $21.17
- Revenue Growth
- AFG 4.76
- BMRN 19.36
- 52 Week Low
- AFG $114.73
- BMRN $52.93
- 52 Week High
- AFG $150.19
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- AFG 54.80
- BMRN 49.81
- Support Level
- AFG $124.81
- BMRN $56.52
- Resistance Level
- AFG $127.61
- BMRN $59.35
- Average True Range (ATR)
- AFG 2.28
- BMRN 1.54
- MACD
- AFG 0.08
- BMRN 0.18
- Stochastic Oscillator
- AFG 76.05
- BMRN 51.79
About AFG American Financial Group Inc.
American Financial Group Inc is a holding company that is engaged in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The Company operates through two segments: Property & Casualty Insurance and Other. The Property & Casualty segment includes Property & Transportation, covering buses, trucks, marine, agriculture, and commercial property; Specialty Casualty, offering excess & surplus, liability, and professional insurance; and Specialty Financial, providing risk management for lending and leasing institutions, fidelity and surety products, and trade credit insurance. The company's insurance operations are conducted through the Great American Insurance Group.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.